Saturday 17 October 2026 Export BCRX’s income statement to Excel — free account

BioCryst Pharmaceuticals, Inc.

BCRX Healthcare Drug Manufacturers Specialty & Generic

BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024. In the quarter to June 2026, revenue grew 33.6%, EPS grew 1,450.0%, free cash flow grew 153.2% and total debt rose 15.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

7.79 0.23 −2.87%

Follow BCRX

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −3.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.83
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	2.05%	(88.68%)	91.07%	87.84%
Piotroski F-Score Full definition →		5	7	4	5
ROA Full definition →		(1.87%)	52.53%	(96.92%)	(75.79%)
ROIC Full definition →		66.46%	245.61%	(356.26%)	(610.55%)
Return on Tangible Assets Full definition →		(5.05%)	121.56%	(244.12%)	(135.02%)
Average Days of Receivables Full definition →		55.57	44.57	45.03	42.98
Free Cash Flow per Share Full definition →		0.23	1.65	1.28	1.47
Free Cash Flow Full definition →		47.86	345.45	310.92	373.93
Capital Expenditures Full definition →		(2.34)	(1.92)	(2.18)	(2.21)
Other line items
Cash ROIC Full definition →		9.60%	54.26%	57.00%	50.66%
Accounts Receivable Turnover Full definition →		7.32	9.41	8.74	9.32
Accounts Payable Turnover Full definition →		1.64	1.39	1.89	2.09
Inventory Turnover Full definition →		2.45	2.83	3.09	3.77
Average Days of Payables Full definition →		129.86	302.83	201.15	199.87
Days of Inventory on Hand Full definition →		122.05	103.29	109.86	105.63
Tax Rate Full definition →		0.33	(0.01)	0.01	0.01
Research and Development Expense of Revenue Full definition →		29.13%	18.99%	21.36%	21.02%
Selling, General and Administrative Expense of Revenue Full definition →		55.58%	39.85%	40.73%	35.86%
Share Based Compensation of Revenue Full definition →		13.77%	9.72%	9.00%	7.77%
Interest Coverage Full definition →		0.85	4.32	(5.08)	(4.16)
Operating CF/Net income Full definition →		(5.72)	1.32	(0.68)	(0.98)
Depreciation/Fixed assets Full definition →		(0.56)	(0.33)	(0.10)	(0.03)
Capex/Depreciation Full definition →		0.50	0.65	2.24	7.08
Revenue per Share Full definition →		2.85	4.17	3.66	3.70
Operating CF per Share Full definition →		0.24	1.66	1.29	1.48
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly